MRCHF Stock Chart & Stats
$22.24
-$1.20(-5.74%)
At close: 4:00 PM EDT
$22.24
-$1.20(-5.74%)
Day’s Range― - ―
52-Week Range$17.25 - $28.93
Previous CloseN/A
Volume100.00
Average Volume (3M)82.00
Market Cap
$1.28B
Enterprise Value$198.15K
Total Cash (Recent Filing)$44.51B
Total Debt (Recent Filing)$60.27B
Price to Earnings (P/E)20.3
Beta0.32
Next Earnings
Nov 05, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend Yield3.64%
Share Statistics
EPS (TTM)172.55
Shares Outstanding57,494,423
10 Day Avg. Volume181
30 Day Avg. Volume82
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.30
Price to Sales (P/S)0.72
P/FCF Ratio9.33
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.61
Revenue Forecast (FY)$1.60B
Bulls Say, Bears Say
Bulls Say
Revenue And Profit RecoveryStrong top-line acceleration and a return to positive earnings indicate renewed demand for diagnostic services and improved operating execution. If sustained, this recovery can rebuild the earnings base over the next several quarters, though normalization is not complete.
Strong Free Cash FlowFree cash flow that broadly tracks net income supports earnings quality and gives the group internally generated funds for investment, debt service, and shareholder distributions. This provides resilience while profitability continues recovering.
Manageable LeverageLower leverage and a sizable equity base improve financial flexibility for a healthcare services group. The stronger balance sheet can help HUGroup absorb operating volatility and fund diagnostic-service development without excessive dependence on external financing.
Bears Say
Subdued Net MarginsAlthough earnings have recovered, profitability remains far below prior peak levels. Persistently thin margins leave less room to absorb wage, logistics, technology, or testing-cost pressure and imply that the current recovery has not yet restored historical earnings power.
Low Return On EquityThe group is generating only modest returns on its equity base despite renewed profitability. This indicates that capital is not yet being converted into shareholder earnings as efficiently as in stronger years, potentially limiting sustainable profit growth until operations improve further.
Weak Cash Conversion Relative To RevenueFree cash flow is currently supportive, but operating cash flow is not especially large relative to revenue. Uneven conversion could make funding capacity less predictable and may signal working-capital or operating-efficiency constraints as the business expands.
HUGroup Holdings News
MRCHF FAQ
What was HUGroup Holdings’s price range in the past 12 months?
HUGroup Holdings lowest stock price was $17.25 and its highest was $28.93 in the past 12 months.
What is HUGroup Holdings’s market cap?
HUGroup Holdings’s market cap is $1.28B.
When is HUGroup Holdings’s upcoming earnings report date?
HUGroup Holdings’s upcoming earnings report date is Nov 05, 2026 which is in 59 days.
How were HUGroup Holdings’s earnings last quarter?
HUGroup Holdings released its earnings results on Aug 12, 2026. The company reported $0.178 earnings per share for the quarter, beating the consensus estimate of $0.103 by $0.075.
Is HUGroup Holdings overvalued?
According to Wall Street analysts HUGroup Holdings’s price is currently Overvalued.
Does HUGroup Holdings pay dividends?
HUGroup Holdings pays a Semiannually dividend of $0.397 which represents an annual dividend yield of 3.64%. See more information on HUGroup Holdings dividends here
What is HUGroup Holdings’s EPS estimate?
HUGroup Holdings’s EPS estimate is 0.15.
How many shares outstanding does HUGroup Holdings have?
HUGroup Holdings has 57,494,423 shares outstanding.
What happened to HUGroup Holdings’s price movement after its last earnings report?
HUGroup Holdings reported an EPS of $0.178 in its last earnings report, beating expectations of $0.103. Following the earnings report the stock price went up 7.746%.
Which hedge fund is a major shareholder of HUGroup Holdings?
Currently, no hedge funds are holding shares in MRCHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HUGroup Holdings
Established in 1950 and headquartered in Tokyo, Japan, H.U. Group Holdings, Inc. (formerly Miraca Holdings Inc. until its rebranding in July 2020) provides an extensive array of laboratory testing products and services through its subsidiaries across Japan. The company delivers diagnostic testing and associated services to medical facilities, supports self-medication initiatives, and conducts testing for food, environmental samples, and cosmetic products. Additionally, it offers testing solutions tailored for corporate health insurance programs. The group is deeply involved in the research, development, manufacturing, and commercialization of in vitro diagnostic devices. Its product lineup features the LUMIPULSE, an automated chemiluminescent enzyme immunoassay system that supplies reagents for the detection of infectious diseases, various cancers, and lifestyle-related conditions to medical institutions and diagnostic centers. H.U. Group also produces the ESPRINE series of rapid diagnostic kits for ailments such as influenza, hepatitis B, and the novel coronavirus, alongside supplying essential ingredients for test drugs. Beyond diagnostics, the company offers crucial support services for hospital administration, including assistance during surgical and endoscope procedures, inspection and maintenance of medical equipment, and in-hospital logistics and transportation management. Furthermore, it addresses the elderly care market by renting and selling specialized equipment and supplies, and by providing in-home nursing care services.
Technical Analysis
Ship Healthcare Holdings
―
Medley
―
Create SD Holdings Co., Ltd.
―
―
Genky DrugStores Co., Ltd.
―
Ownership Overview
―
Insiders
6.93% Mutual Funds
― Other Institutional Investors
86.59% Public Companies and
Individual Investors